Graves' Disease Drugs
Jan 24, 2025
Graves’ Disease Drug Pipeline: 6 Late-Stage Therapies to Watch
The pipeline for Graves’ disease drug treatments is rapidly expanding, with prominent companies such as Immunovant, Viridian Therapeutics, Argenx, Tourmaline Bio, Hoffmann-La Roche, and Sling Therapeutics spearheading the development of targeted therapies for thyroid disorders. Promising candidates in the late stag...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
